Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Clinical applications of metabolomics in oncology: a reviewJennifer L Spratlin, Natalie J Serkova, S Gail Eckhardt
The Lancet. Oncology|September 2, 2008
Targeted manipulation of apoptosis in cancer treatmentJustin A Call, S Gail Eckhardt, D Ross Camidge
Current Opinion in Molecular Therapeutics|November 29, 2007
NMR-based metabolomics: translational application and treatment of cancerNatalie J Serkova, Jennifer L Spratlin, S Gail Eckhardt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
A physiologically based pharmacokinetic model of docetaxel disposition: from mouse to manErica L Bradshaw-Pierce, S Gail Eckhardt, Daniel L Gustafson
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Novel targets in solid tumors: MEK inhibitorsWells A Messersmith, Manuel Hidalgo, Michael Carducci, et al.
Drug News & Perspectives|February 9, 2010
BRCA in breast cancer: from risk assessment to therapeutic predictionJennifer R Diamond, Virginia F Borges, S Gail Eckhardt, et al.
Cancer Journal (Sudbury, Mass.)|June 8, 2010
Novel agents in the treatment of metastatic colorectal cancerStephen Leong, Wells A Messersmith, Aik Choon Tan, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2009
Population pharmacokinetic model of PI-88, a heparanase inhibitorSusan F Hudachek, S Gail Eckhardt, Barbara Hicks, et al.
Therapeutic Advances in Medical Oncology|May 3, 2014
Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkersS Lindsey Davis, S Gail Eckhardt, John J Tentler, et al.
Pageof 21